Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 2/20 | 0.30 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.30 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.30 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20866963 | 0.96 | PIK3CD (0.30) | PIK3CDPIK3CAPIK3CBSMN1; SMN2PIK3CG | |
| SCHEMBL20867257 | 0.84 | SYK (0.31) | — | |
| SCHEMBL20866762 | 0.84 | PIK3CA (0.30) | PIK3CA | |
| SCHEMBL20866691 | 0.81 | MAPK1 (0.31) | SMN1; SMN2KDM4EALDH1A1GAAMAPT | |
| SCHEMBL20867295 | 0.81 | — | — | |
| SCHEMBL24612210 | 0.76 | FBP1 (0.31) | KDM4E | |
| SCHEMBL20866838 | 0.76 | ATM (0.32) | PIK3CDPIK3CAPIK3CBSMN1; SMN2KDM4E | |
| SCHEMBL24612293 | 0.75 | ATM (0.31) | SMN1; SMN2KDM4EALDH1A1GAAMAPT | |
| SCHEMBL20867306 | 0.74 | ATM (0.31) | — | |
| SCHEMBL20866960 | 0.73 | ATM (0.32) | PIK3CDPIK3CAPIK3CBSMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3324977-B1 | BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS | ENANTA PHARM INC (US) | 2022-07-13 | — | — | EP | disclosed |